JAK2 and dry eye syndrome: Park et al. demonstrated that the TNF-α and IL-6 produced by KCs may activate pro-oncogenic pathways via JNK signal transducer and activator of STAT3, Janus kinase 2 (JAK2), MAPK, and PI3K.